Rockwell Medical Technologies Inc.
30142 Wixom Road
Wixom,
MI 48393
United States - Map
Phone: 248-960-9009
Fax: 248-960-9109
Web Site: http://www.rockwellmed.com
| Rockwell Medical Technologies, Inc. engages in the manufacture, sale, and distribution of hemodialysis concentrate solutions and dialysis kits primarily to hemodialysis providers in the United States, Latin America, Asia, and Europe. The company’s products are used to cleanse patient’s blood and replace nutrients lost during the kidney dialysis process. Its hemodialysis concentrates include acid concentrates consisting of sodium chloride, dextrose, and electrolyte additives, such as magnesium, potassium, and calcium; Dri-Sate dry acid concentrate; bicarbonate products; and SteriLyte liquid bicarbonate that is used in acute care and chronic care settings. The company also offers a range of ancillary products, including blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. In addition, it manufactures and sells iron supplemented dialysate, which is used for the treatment of dialysis patients with iron deficiency that is pervasive in the dialysis patient population. The company markets its products through independent sales agents and distributors. Rockwell Medical Technologies was founded in 1995 and is based in Wixom, Michigan. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Robert L. Chioini , 43
Founder, Chairman, Chief Exec. Officer, Pres and Member of Stock Option Committee |
N/A
| N/A | Mr. Thomas E. Klema , 54
Chief Financial Officer, Principal Accounting Officer, VP of Fin., Sec. and Treasurer |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-07
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
2.63% Nasdaq 0.00%
Profile
